Evaluation Sub-Committee - Applications Considered
- 1387.2 – Optimizer smart implantable pulse generator – Cardiac contractility modulation therapy for patients with chronic heart failure
- 1431.1 - HbA1c point-of-care test for the diagnosis and management of diabetes mellitus
- 1518 - Endoscopic visual laser ablation of the prostate for benign prostatic hyperplasia
- 1531 - Alpha thalassaemia genetic testing
- 1532 - Expansion of MBS item 73325 to include additional populations and mutations beyond those currently specified
- 1534 - Heritable mutations associated with familial hypercholesterolaemia
- 1562 - Streamlining of MSAC assessment of positron emission tomography project (preliminary consideration)